Sequence supplied with the lot CoA
CAS 2023788-19-2Enhanced verificationMade to order · 2–6 weeks
Tirzepatide
Dual GIP / GLP-1 receptor agonist
4813 g/mol · ≥98% (HPLC)
Verified orders. Each order needs institutional verification and a signed end-use statement before it ships. Orders above typical research quantities are reviewed first. Why
About this peptide
39-residue acylated peptide acting on both GIP and GLP-1 receptors. Used to compare dual-incretin with single-receptor signalling.
Reported research uses
- 01GIPR and GLP-1R dual-agonism assays
- 02Metabolic and adipose-tissue research models
- 03Analytical reference material
Specifications
- CAS number
- 2023788-19-2
- Molecular formula
- C₂₂₅H₃₄₈N₄₈O₆₈
- Molecular weight
- 4813 g/mol
- Purity
- ≥98% (HPLC)
- Counter-ion
- TFA (acetate on request)
- Appearance
- Lyophilised white powder
- Storage
- −20 °C, desiccated, protected from light
- Synonyms
- LY3298176; GIP/GLP-1 co-agonist
Values from the manufacturer’s documents and published sources, for reference only; the lot CoA is the reference. Reported uses are from the literature and are not a claim that the product is suitable or safe for any purpose. For laboratory research use only — not for human or veterinary use. Handle only by trained staff following the SDS. Synthesised after your order is verified; MS and HPLC data come with the lot.